Eric Schadt joined Pathos as Chief Scientific Officer and maintains a continuing faculty role at the Icahn School of Medicine at Mount Sinai (ISMMS). Prior to joining Pathos, Schadt was founding CEO and then chief R&D officer of Sema4 (now GeneDx), a next-generation, information-driven precision medicine company developing advanced genomic testing solutions to enable genomic medicine.

He has also served as chairman of the Department of Genetics and Genomic Sciences and founding director of the Icahn Institute for Genomics and Multiscale biology at ISMMS (2012-2018), as CSO of Pacific Biosciences (2009-2011), and varying scientific leadership roles at Merck, Rosetta Inpharmatics, and Roche.

Schadt has his undergraduate training in computer science and math from Cal Poly, San Luis Obispo, a Master’s in Pure Mathematics from UC Davis, and a PhD in Biomathematics from UCLA. He is considered a pioneer in developing and applying integrative computational biology methods to very large-scale data to further our understanding of disease and wellness (co-author of more than 500 peer-reviewed papers and an h-index of 146).

• 

  Chief Scientific Officer (CSO) in Pathos

  The AI-Driven Biotechnology Company